Some scholars reported that patients with squamous cell carcinoma of the head and neck, gastric cancer, and metastatic melanoma who were effective against PD-1 had higher expression levels of IFN-γ-related genes than ineffective patients [37]. This evidence concerns the gene IFNG and gastric cancer.